恶性肿瘤对外周动脉疾病患者肢体预后的影响:基于全国数据库的真实世界分析
结果显示,恶性肿瘤组与非恶性肿瘤组的原发性通畅率和免于MALE率无差异,但恶性肿瘤组总体生存率显著更差,而心血管死亡率无显著差异。结论认为恶性肿瘤不影响CLTI患者术后肢体预后,不应避免血运重建。
要点
- PAD合并CLTI患者血运重建时恶性肿瘤患病率约2.1%。
- 恶性肿瘤不影响原发性通畅率及免于MALE率。
- 恶性肿瘤患者总体生存更差,但心血管死亡率无差异。
核心结论
- 恶性肿瘤存在不影响CLTI患者血运重建后的肢体预后,不应因此避免最佳血运重建。
主要发现
- 恶性肿瘤组与非恶性肿瘤组的原发性通畅率和免于MALE率无差异,无论治疗方式。
- 恶性肿瘤组总体生存率显著更差,但心血管死亡率无显著差异。
临床怎么用
- 对于合并恶性肿瘤的CLTI患者,若病情和预期寿命允许,仍应进行最佳血运重建包括外科手术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: It is unclear how malignant neoplasms affect limb prognosis in patients with peripheral arterial disease (PAD). The purpose of this study was to clarify the association between malignant neoplasms and limb outcomes in patients with PAD complicated by chronic limb threatening ischaemia (CLTI). METHODS: Data for patients who underwent revascularisation between 2013 - 2015 were collected from the JAPAN Chronic Limb Threatening Ischaemia Database (JCLIMB), established as a part of the National Clinical Database. All patients included in this study had PAD with CLTI and were followed for two years. The prevalence of malignant neoplasms at the time of revascularisation was examined. Overall survival, cardiovascular death, primary patency, and major adverse limb events (MALEs) were also investigated. RESULTS: The 2 891 patients included in the study underwent surgical revascularisation (including hybrid treatment) in 1 709 cases and endovascular treatment in 1 182 cases. Overall, 62 patients (2.1%) had malignant neoplasms at the time of revascularisation (malignancy bearing group). Primary patency and MALE free rates did not differ between patients with and without malignant neoplasms, regardless of treatment type. Overall survival was statistically significantly poorer in the malignancy bearing than in the malignancy free group. The cardiovascular mortality rate was not statistically significantly different between the malignancy bearing and malignancy free groups, regardless of treatment modality. CONCLUSION: Approximately 2% of patients with PAD complicated by CLTI had a malignant neoplasm at the time of revascularisation. The presence of malignant neoplasms did not impact post-operative limb prognosis in patients with CLTI. Therefore, even if diagnosed with malignant neoplasms, there is no need to avoid performing optimal revascularisation for CLTI, including surgical revascularisation, provided the patient's condition and life prognosis are acceptable.
引用
- Miyama N, Komori K, Takahashi A, et al. Influence of Malignant Neoplasms on Limb Prognosis in Patients with Peripheral Arterial Disease: A Real World Analysis Based on a Nationwide Database. Eur J Vasc Endovasc Surg. 2026. PMID: 41616866. doi:10.1016/j.ejvs.2026.01.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。